PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Blood poisoning keeping many people out of work

2023-12-28
(Press-News.org) A few years ago, the World Health Organization estimated that blood poisoning, or sepsis, is involved in one in five deaths in the world. 11 million people die from sepsis each year, of which nearly 3 million are children.

This is also a problem in Norway, with thousands of people affected every year.

“Sepsis is a severe immunological overreaction to an infection. It causes the body’s organs to fail,” says Nina Vibeche Skei. She is a doctoral research fellow at the Norwegian University of Science and Technology (NTNU) and a senior anaesthetist at Levanger Hospital.

In Norway, 3000 people die every year from sepsis.

“Many people believe that sepsis only affects the elderly, but a third of those who survive are between the ages of 18 and 60, and this has many consequences,” says doctoral research fellow Skei.

Many years of diminished health Patients who survive sepsis may have health problems and reduced quality of life for years after they are discharged. Many develop a new chronic disorder or exacerbation of existing chronic conditions, or ailments due to organ failure and intensive care.

“Even everyday activities can become a challenge,” says Skei.

As a result, many people do not return to work after having sepsis, but until now, we have not known how many.

“We investigated the percentage of sepsis patients who returned to work in Norway,” says Lise Tuset Gustad. She is a researcher at the Faculty of Nursing and Health Sciences at Nord University and Levanger Hospital.

High levels of occupational disability among people with sepsis The research group they were part of retrieved figures from the Norwegian Patient Registry and from the Norwegian Labour and Welfare Administration’s information on absence due to illness. The figures included 36,000 sepsis patients aged 18 to 60. The researchers looked at whether they had returned to work six months, one year and two years after they had been discharged from hospital.

After six months, less than 59 percent of the patients had returned to work. After one year, just over 67 percent were back at work. However, after two years, the number was down to just over 63 percent.

In other words, almost four out of ten of those who had had sepsis were out of work two years after contracting the illness.

Several determining factors Several factors come into play regarding who is able to return to work after having sepsis.

“Those who fared best were young people with few additional chronic diagnoses and less extensive organ failure,” says Skei.

50- to 60-year-olds were 31 percent less likely to return to work than people aged 18 to 30. People with a chronic illness were 54 percent less likely to return to work, compared with those without a chronic illness. People who had two organs that failed were 40 percent less likely to return to work than those who suffered only one organ failure.

“In addition, people who required intensive care had almost a 50 percent reduced chance of returning to work, compared with those who were admitted to a ward,” says Gustad.

This is because the individuals who require intensive care often have more severe sepsis. Only 52 percent of those admitted to an intensive care unit, compared with 64 percent of those admitted to a ward, were back at work 2 years after discharge.

The researchers also investigated people who contracted sepsis as a result of COVID-19. This group was 31 percent more likely to return to work than the rest of the patients with sepsis.

No improvement “The main finding of this study is that sepsis greatly reduces the chances of returning to work,” says Skei.

Unfortunately, there is nothing to indicate that we have become better in Norway at getting sepsis patients back to work. The figures were from the period 2010 to 2021, enabling the researchers to document changes.

“Developments over the past decade show no improvement. In fact, the percentage of people who were in work two years after discharge from a hospital ward fell from 70 percent in 2016 to 57 percent in 2019. The reasons for this should be investigated further. We can then implement targeted measures to improve the consequences of sepsis,” says Gustad.

Reference: Skei, N.V., Moe, K., Nilsen, T.I.L. et al. Return to work after hospitalization for sepsis: a nationwide, registry-based cohort study. Crit Care 27, 443 (2023). https://doi.org/10.1186/s13054-023-04737-7

END


ELSE PRESS RELEASES FROM THIS DATE:

Oral peptides: A new era in drug development

Oral peptides: A new era in drug development
2023-12-28
For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy. Traditional small molecules often struggle to bind to proteins with flat surfaces or require specificity for particular protein homologs. Typically, larger biologics that can target these proteins demand injection, limiting patient convenience and accessibility. In a new study published in Nature Chemical Biology, scientists from the laboratory of Professor Christian Heinis at EPFL have achieved a significant milestone in drug development. Their research ...

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
2023-12-28
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition. AFCR’s BRACE (Bridging Research from Academia to Cancer Entrepreneurship) Award Venture Competition is designed to support and accelerate oncology innovations on their path toward commercialization, with the ultimate goal of improving outcomes for patients affected by cancer globally. AFCR aims to support the winners of the BRACE Award with funding resources, advisory experts, and access to our global network of key opinion leaders in cancer research. The winner of the BRACE ...

Social media platforms generate billions in annual ad revenue from US youth

2023-12-27
Embargoed for release: December 27, 2023, 2:00 PM ET Key points: Researchers estimated that Facebook, Instagram, Snapchat, TikTok, X (formerly Twitter), and YouTube collectively derived nearly $11 billion in advertising revenue during 2022 from U.S. youth, who are vulnerable to negative mental health outcomes. The study is the first to offer estimates of the number of youth users on these platforms and how much annual ad revenue is attributable to them. According to the researchers, the study’s ...

Virtual care works best when patients see their own family doctor, study finds

Virtual care works best when patients see their own family doctor, study finds
2023-12-27
Toronto, ON, December 27, 2023 – Compared to patients who had a virtual visit with their own family doctor, those who received virtual care from a doctor outside of their family care team were 66 percent more likely to visit the emergency department within seven days, according to new research. The study, led by researchers at the University Health Network (UHN), Unity Health Toronto, and ICES, also showed that patients receiving virtual care outside of an existing family doctor-patient relationship were 25 percent more likely to have an in-person visit and 88 percent more likely to have another virtual visit within seven days. “This study sheds light on how different types ...

Consistency and accuracy of AI for providing nutritional information

2023-12-27
About The Study: The results of this study suggest that artificial intelligence (AI) can be a useful and convenient tool for people who want to know the energy and macronutrient information of their foods. Although AI chatbots cannot replace nutritionists, they may provide real-time analysis of foods, and the capacity to harness AI technology in a supportive role may fundamentally transform the way nutritionists communicate with patients.  Authors: Jung-Su Chang, Ph.D., of Taipei Medical University in Taipei, Taiwan, is the corresponding author.  To ...

Low-carbohydrate diet macronutrient quality and weight change

2023-12-27
About The Study: In this study using data from three large prospective cohort studies among 123,000 individuals, low-carbohydrate diets that emphasized high-quality proteins, fats and carbohydrates from whole grains and other healthy plant-based foods were significantly associated with slower weight gain in the long term. In contrast, low-carbohydrate diets emphasizing animal-sourced proteins and fats or refined carbohydrates were associated with faster weight gain. Authors: Qi Sun, M.D., Sc.D., of the Harvard T.H. Chan School of Public Health in Boston, is the corresponding author.  To access the ...

Benzodiazepine use during pregnancy and risk of miscarriage

2023-12-27
About The Study: This nationwide case-time-control study revealed an increased risk of miscarriage associated with benzodiazepine use during pregnancy after accounting for measurable confounders, and results were unlikely to be due to unmeasured confounding. These findings underscore the necessity for health care professionals to meticulously balance the risk-benefit ratio when considering the use of benzodiazepines to treat psychiatric and sleep disorders during pregnancy.  Authors: Fei-Yuan Hsiao, Ph.D., of National ...

Comparison of capture rates of the National Cancer Database across race and ethnicity

2023-12-27
About The Study: In this study of individuals diagnosed with cancer in the National Cancer Database (NCDB), Hispanic and American Indian or Alaska Native individuals diagnosed with breast, colorectal, lung, and prostate cancer were undercaptured in the NCDB, but their representation improved over time. Increased study is needed to determine where these populations predominantly seek cancer care.  Authors: Juan Javier-DesLoges, M.D., M.S., of the University of California, San Diego, is the corresponding author.  To ...

A study of the genetics of pericarditis increases understanding of newly approved drug treatment

A study of the genetics of pericarditis increases understanding of newly approved drug treatment
2023-12-27
A study of the genetics of pericarditis increases understanding of newly approved drug treatment Sequence variants that protect against pericarditis have been discovered at a genomic locus encoding interleukin-1 immune cytokines. A newly approved drug treatment for pericarditis inhibits these cytokines and new a study from deCODE genetics and collaborators can contribute to the further development of this treatment. A new study called “Variants at the interleukin-1 gene locus and pericarditis” was published today in the journal JAMA Cardiology, by scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Denmark, USA, and Iceland. The study involves ...

New reptile on the block: A new iguana species discovered in China

New reptile on the block: A new iguana species discovered in China
2023-12-27
A new iguana joins Asia’s rich reptile fauna, officially described as new to science in the open-access journal ZooKeys. “From 2009 to 2022, we conducted a series of field surveys in South China and collected a number of specimens of the Calotes versicolor species complex, and found that the population of what we thought was Calotes versicolor in South China and Northern Vietnam was a new undescribed species and two subspecies,” says Yong Huang, whose team described the new species. Wang’s garden ...

LAST 30 PRESS RELEASES:

Has the affordable care act’s dependent coverage expansion benefited young adults diagnosed with cancer?

A new study reveals a key mechanism driving atherosclerosis in Hutchinson-Gilford Progeria Syndrome

HPV vaccination switch to 1-dose gender-neutral approach

Scurvy: Not just an 18th-century sailors’ disease

Scientists discover a secret to regulating our body clock, offering new approach to end jet lag

Impact of pollutants on pollinators, and how neural circuits adapt to temperature changes

Researchers seek to improve advanced pain management using AI for drug discovery

‘Neutron Nexus’ brings universities, ORNL together to advance science

Early release from NEJM Evidence

UMass Amherst astronomer leads science team helping to develop billion-dollar NASA satellite mission concept

Cultivating global engagement in bioengineering education to train students skills in biomedical device design and innovation

Life on Earth was more diverse than classical theory suggests 800 million years ago, a Brazilian study shows

International clean energy initiative launches global biomass resource assessment

How much do avoidable deaths impact the economy?

Federal government may be paying twice for care of veterans enrolled in Medicare Advantage plans

New therapeutic target for cardiac arrhythmias emerges

UC Irvine researchers are first to reveal role of ophthalmic acid in motor function control

Moffitt study unveils the role of gamma-delta T cells in cancer immunology

Drier winter habitat impacts songbirds’ ability to survive migration

Donors enable 445 TPDA awards to Neuroscience 2024

Gut bacteria engineered to act as tumor GPS for immunotherapies

Are auditory magic tricks possible for a blind audience?

Research points to potential new treatment for aggressive prostate cancer subtype

Studies examine growing US mental health safety net

Social risk factor domains and preventive care services in US adults

Online medication abortion direct-to-patient fulfillment before and after the Dobbs v Jackson decision

Black, Hispanic, and American Indian adolescents likelier than white adolescents to be tested for drugs, alcohol at pediatric trauma centers

Pterosaurs needed feet on the ground to become giants

Scientists uncover auditory “sixth sense” in geckos

Almost half of persons who inject drugs (PWID) with endocarditis will die within five years; women are disproportionately affected

[Press-News.org] Blood poisoning keeping many people out of work